insights_auto
Why is MANKIND down 3.07%?
Dive Deeperchevron_right
MANKIND:NSE
Mankind Pharma Ltd
₹2,275.50
arrow_downward
-3.07%(-72.10) 1D
Oct 16, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MANKIND...
Open
₹2,349.90
High
₹2,354.40
Low
₹2,268.70
Mkt. cap
937.40B
Avg. vol.
483.95K
Volume
889.73K
P/E ratio
46.04
52-wk high
₹2,642.00
52-wk low
₹1,909.70
EPS
₹49.42
No. of employees
20K
Open
₹2,349.90
High
₹2,354.40
Low
₹2,268.70
Mkt. cap
937.40B
Avg. vol.
483.95K
Volume
889.73K
P/E ratio
46.04
52-wk high
₹2,642.00
52-wk low
₹1,909.70
EPS
₹49.42
No. of employees
20K
News stories
From web sources and news partners
Yahoo Finance
·
48 minutes ago
3 Reasons the Vanguard S&P 500 ETF Could Be Worth Holding for the Next 20 Years
ad-hoc-news.de
·
2 hours ago
Dow reports on October 22, 2026: Dow stock stands at USD 29.93
Traders Union
·
7 hours ago
S&P 500 posts one new low for second day, Ryan Detrick notes
TOKENPOST
·
3 hours ago
S&P 500 Earnings Season Shows 83% of Early Firms Beat Estimates
Profile
Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications.
As of 2023, Mankind Pharma had 25 factories and 6 R&D centres in India. The company derived 97% of its operating revenue from the Indian market, where it is reportedly the fourth largest pharmaceutical company by domestic sales. Some of Mankind Pharma's consumer healthcare brands are the largest-selling in their respective categories, including Manforce in condoms, Prega News in pregnancy test kits, and Unwanted-72 in emergency contraception. Wikipedia
About Mankind Pharma Ltd
CEORajeev Juneja | Sheetal Arora
Employees20.5K
Founded1991
Headquarters-
SectorPharmaceutical industry
Websitemankindpharma.com